Professor Dr. Paul Valdmanis
Associate Professor
Build a Statement of Purpose
Generate a tailored SOP for Dr. Paul Valdmanis. Improve your application with a focused, well-structured draft.
Biography
Paul Valdmanis completed his Bachelor of Science in Biochemistry summa cum laude at the University of Ottawa. He earned his PhD in the laboratory of Guy Rouleau at McGill University in Montreal, Canada, focusing on the identification of pathogenic variants in genes responsible for Amyotrophic Lateral Sclerosis (ALS), Hereditary Spastic Paraplegia, and Sensory Ataxia. His postdoctoral research at Stanford University involved utilizing adeno-associated viral delivery systems for gene therapy. He joined the Division of Medical Genetics at the University of Washington in 2017 as an Associate Professor. His research aims to identify genetic contributors to neurodegenerative diseases and develop gene therapy methods. He has received numerous awards for his work, including the Governor General’s Gold Medal from McGill University and the American Society for Gene & Cell Therapy Research Excellence Award.
Research Interests
Experience
Associate Professor
— PresentUniversity of Washington • Seattle, WA
Joined the Division of Medical Genetics, conducting research on genetic factors contributing to neurodegenerative diseases.
Awards
Roger Guindon Scholarship
CIHR Institute of Neurosciences Brain Star Award
Governor General’s Gold Medal
American Society for Gene & Cell Therapy Research Excellence Award
American Society for Gene & Cell Therapy Travel Award
Robert F. Schoeni Award
Requirements for University of Washington
Master Program
Requirements
GPA Requirement
TOEFL
IELTS
Duolingo
Prerequisites
Application Checklist
- Online application
- Transcripts
- Statement of Purpose
- Letters of Recommendation
- Resume/CV
- English proficiency scores (for international students)
Specialization Notes
Standard Graduate School requirements for University of Washington apply to most departments listed unless specified otherwise by the program.